Céline Cano

2.0k citations

54 papers · 1.3k indexed · h-index 21

Impact in

Toxicology top 2%
Oncology top 10%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy

Papers in ⓘ

Toxicology 11
- Bioactive Compounds and Antitumor Agents 9
Organic Chemistry 22
- Synthesis and Biological Evaluation 6

Co-authors: Roger J. Griffin (28 shared papers)Ian R. Hardcastle (25 shared papers)Bernard T. Golding (28 shared papers)David R. Newell (16 shared papers)Nicola J. Curtin (10 shared papers)Suzannah J. Harnor (9 shared papers)Simon H. L. Thomas (2 shared papers)S. Hill (2 shared papers)
Journals: Organic & Biomolecular Chemistry (8 papers)Journal of Medicinal Chemistry (7 papers)Oncotarget (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Clinical Chemistry (3 papers)
Partner nations: United Kingdom United States Japan

In The Last Decade

Céline Cano

53 papers receiving 1.3k citations

Peers

Countries citing papers authored by Céline Cano

Since Specialization

Citations

This map shows the geographic impact of Céline Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Cano more than expected).

Fields of papers citing papers by Céline Cano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Cano. The network helps show where Céline Cano may publish in the future.

Co-authors

The 25 scholars most cited alongside Céline Cano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Céline Cano Line = papers co-authored together Céline Cano links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K Molecular Cancer Therapeutics ·Joanne M. Munck, Michael A. Batey, Yan Zhao, Helen Jenkins, Caroline J. Richardson, Céline Cano, Michele Tavecchio, Jody Barbeau, Julia Bárdos, Liam Cornell, Roger J. Griffin, Keith Menear, Andrew Slade, Pia Thömmes, Niall M.B. Martin, David R. Newell, Graeme C.M. Smith, Nicola J. Curtin	2012	99
2	Identification and Characterization of an Irreversible Inhibitor of CDK2 Chemistry & Biology ·Elizabeth Anscombe, Elisa Meschini, Regina Mora-Vidal, Mathew P. Martin, David Staunton, Matthis Geitmann, U. Helena Danielson, Will A. Stanley, Lan Z. Wang, Tristan Reuillon, Bernard T. Golding, Céline Cano, David R. Newell, M.E.M. Noble, Stephen R. Wedge, Jane Endicott, Roger J. Griffin	2015	95
3	Synthetic cannabinoid receptor agonists: classification and nomenclature Clinical Toxicology ·Adam Potts, Céline Cano, Simon H. L. Thomas, S. Hill	2019	76
4	DNA-Dependent Protein Kinase Is a Therapeutic Target and an Indicator of Poor Prognosis in B-Cell Chronic Lymphocytic Leukemia Clinical Cancer Research ·Elaine Willmore, Sarah L. Elliott, Tryfonia Mainou‐Fowler, Geoffrey Summerfield, Graham Jackson, Fran O'Neill, Christopher J. Lowe, Anthony Carter, Robert J. Harris, Andrew R. Pettitt, Céline Cano, Roger J. Griffin, Ian G. Cowell, Caroline A. Austin, Barbara W. Durkacz	2008	73
5	Targeting DNA‐Dependent Protein Kinase for Cancer Therapy ChemMedChem ·Suzannah J. Harnor, Alfie Brennan, Céline Cano	2017	64
6	FragLites—Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation Journal of Medicinal Chemistry ·D.J. Wood, J. Daniel Lopez‐Fernandez, Leanne E. Knight, Islam Al-Khawaldeh, Conghao Gai, Shengying Lin, Mathew P. Martin, Duncan C. Miller, Céline Cano, Jane Endicott, Ian R. Hardcastle, M.E.M. Noble, Michael J. Waring	2019	62
7	Pyranone, Thiopyranone, and Pyridone Inhibitors of Phosphatidylinositol 3-Kinase Related Kinases. Structure−Activity Relationships for DNA-Dependent Protein Kinase Inhibition, and Identification of the First Potent and Selective Inhibitor of the Ataxia Telangiectasia Mutated Kinase Journal of Medicinal Chemistry ·Jonathan J. Hollick, Laurent Rigoreau, Céline Cano, Xiaoling Cockcroft, Nicola J. Curtin, Mark Frigerio, Bernard T. Golding, Sophie Guiard, Ian R. Hardcastle, Ian Hickson, Marc Hummersone, Keith Menear, Niall M.B. Martin, Ian Matthews, David R. Newell, Rachel Ord, Caroline J. Richardson, Graeme C.M. Smith, Roger J. Griffin	2007	61
8	Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination Cancer Chemotherapy and Pharmacology ·Michele Tavecchio, Joanne M. Munck, Céline Cano, David R. Newell, Nicola J. Curtin	2011	53
9	Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo antitumour activity in colorectal cancer British Journal of Cancer ·Gary Beale, Emma J. Haagensen, Huw D. Thomas, Lan-Zhen Wang, Charlotte Revill, Sara L. Payne, Bernard T. Golding, Ian R. Hardcastle, David R. Newell, Roger J. Griffin, Céline Cano	2016	45
10	Recent Advances in CDK Inhibitors for Cancer Therapy Future Medicinal Chemistry ·Amy B. Heptinstall, IWS Adiyasa, Céline Cano, Ian R. Hardcastle	2018	43
11	1-Substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones Endowed with Dual DNA-PK/PI3-K Inhibitory Activity Journal of Medicinal Chemistry ·Céline Cano, Kappusamy Saravanan, Chris Bailey, Julia Bárdos, Nicola J. Curtin, Mark Frigerio, Bernard T. Golding, Ian R. Hardcastle, Marc Hummersone, Keith Menear, David R. Newell, Caroline J. Richardson, Kerry Shea, Graeme C.M. Smith, Pia Thömmes, Attilla Ting, Roger J. Griffin	2013	42
12	DNA-Dependent Protein Kinase (DNA-PK) Inhibitors. Synthesis and Biological Activity of Quinolin-4-one and Pyridopyrimidin-4-one Surrogates for the Chromen-4-one Chemotype Journal of Medicinal Chemistry ·Céline Cano, Olivier Barbeau, C. L. Bailey, Xiaoling Cockcroft, Nicola J. Curtin, Heather M. E. Duggan, Mark Frigerio, Bernard T. Golding, Ian R. Hardcastle, Marc Hummersone, Charlotte Knights, Keith Menear, David R. Newell, Caroline J. Richardson, Graeme C. M. Smith, Ben Spittle, Roger J. Griffin	2010	35
13	A beginner’s guide to current synthetic linker strategies towards VHL-recruiting PROTACs Bioorganic & Medicinal Chemistry ·Nikol A. Zografou-Barredo, Alex J. Hallatt, J. S. JUN. RICCI, Céline Cano	2023	34
14	Trifluoroacetic Acid in 2,2,2‐Trifluoroethanol Facilitates S_NAr Reactions of Heterocycles with Arylamines Chemistry - A European Journal ·Benoît Carbain, Christopher R. Coxon, Honorine Lebraud, Kristopher J. Elliott, Christopher J. Matheson, Elisa Meschini, Amy R. Roberts, David M. Turner, Christopher Wong, Céline Cano, Roger J. Griffin, Ian R. Hardcastle, Bernard T. Golding	2014	31
15	Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer Oncotarget ·Judith E. Unterlass, Arnaud Baslé, Timothy J. Blackburn, Julie A. Tucker, Céline Cano, M.E.M. Noble, Nicola J. Curtin	2016	29
16	Structural insights into the enzymatic activity and potential substrate promiscuity of human 3-phosphoglycerate dehydrogenase (PHGDH) Oncotarget ·Judith E. Unterlass, R.J.K. Wood, Arnaud Baslé, Julie A. Tucker, Céline Cano, M.E.M. Noble, Nicola J. Curtin	2017	24
17	Synthesis and biological evaluation of 5-substituted O4-alkylpyrimidines as CDK2 inhibitors Organic & Biomolecular Chemistry ·Francesco Marchetti, Céline Cano, Nicola J. Curtin, Bernard T. Golding, Roger J. Griffin, Karen Haggerty, David R. Newell, Rachel Parsons, Sara L. Payne, Lan Z. Wang, Ian R. Hardcastle	2010	23
18	Model system for irreversible inhibition of Nek2: thiol addition to ethynylpurines and related substituted heterocycles Organic & Biomolecular Chemistry ·Honorine Lebraud, Christopher R. Coxon, Victoria S. Archard, Carlo Bawn, Benoît Carbain, Christopher J. Matheson, David M. Turner, Céline Cano, Roger J. Griffin, Ian R. Hardcastle, U. Baisch, Ross W. Harrington, Bernard T. Golding	2013	21
19	8-Substituted O⁶-Cyclohexylmethylguanine CDK2 Inhibitors: Using Structure-Based Inhibitor Design to Optimize an Alternative Binding Mode Journal of Medicinal Chemistry ·Benoît Carbain, David J. Paterson, Elizabeth Anscombe, Allyson J. Campbell, Céline Cano, Aude Echalier, Jane Endicott, Bernard T. Golding, Karen Haggerty, Ian R. Hardcastle, Philip J. Jewsbury, David R. Newell, M.E.M. Noble, C. Roche, Lan Z. Wang, Roger J. Griffin	2013	21
20	Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives Organic & Biomolecular Chemistry ·K.M. Clapham, Tommy Rennison, Gavin O. Jones, Faye Craven, Julia Bárdos, Bernard T. Golding, Roger J. Griffin, Karen Haggerty, Ian R. Hardcastle, Pia Thömmes, Attilla Ting, Céline Cano	2012	20

About Céline Cano

Céline Cano is a scholar working on Toxicology, Organic Chemistry, Oncology, Molecular Biology and Pharmaceutical Science, having authored 54 papers that have together received 1.3k indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (9 papers), Cancer therapeutics and mechanisms (9 papers), Protein Degradation and Inhibitors (6 papers), Cancer-related Molecular Pathways (6 papers), DNA Repair Mechanisms (6 papers), Synthesis and Biological Evaluation (6 papers), Chemical Synthesis and Analysis (4 papers) and Microtubule and mitosis dynamics (4 papers). The work is most often cited by research in Toxicology (118 citations), Oncology (387 citations), Organic Chemistry (369 citations), Molecular Biology (834 citations) and Cancer Research (102 citations). Céline Cano has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Roger J. Griffin, Ian R. Hardcastle, Bernard T. Golding, David R. Newell, Nicola J. Curtin, Suzannah J. Harnor, Simon H. L. Thomas, S. Hill, M.E.M. Noble and Caroline J. Richardson. Their work appears in journals such as Organic & Biomolecular Chemistry, Journal of Medicinal Chemistry, Oncotarget, Bioorganic & Medicinal Chemistry Letters and Clinical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact